Chemoinformaics analysis of Furo[2,3-b]quinoline, 4,5-dimethoxy-
| Molecular Weight | 229.235 | nRot | 2 |
| Heavy Atom Molecular Weight | 218.147 | nRig | 15 |
| Exact Molecular Weight | 229.074 | nRing | 3 |
| Solubility: LogS | -3.486 | nHRing | 2 |
| Solubility: LogP | 2.925 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 15 |
| nHA | 4 | APOL | 32.5507 |
| nHD | 0 | BPOL | 17.3833 |
| QED | 0.677 |
| Synth | 2.474 |
| Natural Product Likeliness | 0.618 |
| NR-PPAR-gamma | 0.92 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.015 |
| CACO-2 | -4.764 |
| MDCK | 0.0000313 |
| BBB | 0.649 |
| PPB | 0.883903 |
| VDSS | 0.402 |
| FU | 0.0688056 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.956 |
| CYP2c19-inh | 0.918 |
| CYP2c19-sub | 0.528 |
| CYP2c9-inh | 0.66 |
| CYP2c9-sub | 0.896 |
| CYP2d6-inh | 0.697 |
| CYP2d6-sub | 0.908 |
| CYP3a4-inh | 0.747 |
| CYP3a4-sub | 0.414 |
| CL | 7.62 |
| T12 | 0.488 |
| hERG | 0.108 |
| Ames | 0.819 |
| ROA | 0.719 |
| SkinSen | 0.214 |
| Carcinogencity | 0.812 |
| EI | 0.252 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.739 |
| Antiviral | Yes |
| Prediction | 0.688192 |